BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
1540991	Cc1cc(NC(=O)C(O)c2cccc(F)c2)ccc1-c1nc(C)n2ccnc(N)c12			750178	N-(4-(8-amino-3- methylimidazo[1,5- a]pyrazin-1-yl)-3- methylphenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 1	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750178	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750178&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118263	519648772							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1540992	Cc1cc(NC(=O)C(O)c2cccc(F)c2)ccc1-c1nc(C)n2ccnc(N)c12			750179	N-(4-(8-amino-3- methylimidazo[1,5- a]pyrazin-1-yl)-3- methylphenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 2	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 38							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750179	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750179&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118263	519648773							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1540993	Cc1cn2c(C)nc(-c3ccc(NC(=O)C(O)c4cccc(F)c4)cc3C)c2c(N)n1			750180	N-(4-(8-amino-3,6- dimethylimidazo[1,5- a]pyrazin-1-yl)-3- methylphenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 3	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750180	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750180&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118267	519648774							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1540994	Cc1cn2c(C)nc(-c3ccc(NC(=O)C(O)c4cccc(F)c4)cc3C)c2c(N)n1			750181	N-(4-(8-amino-3,6- dimethylimidazo[1,5- a]pyrazin-1-yl)-3- methylphenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 4	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 75							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750181	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750181&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118267	519648775							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1540995	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)cc2C)c2c(N)nc(C)cn12			750182	N-(4-(8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl)-3- methylphenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 5	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750182	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750182&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118207	519648776							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1540996	Cc1cc(NC(=O)C(O)c2cccc(F)c2)ccc1-c1nc(C)n2c(C)cnc(N)c12			750183	N-(4-(8-amino-3,5- dimethylimidazo[1,5- a]pyrazin-1-yl)-3- methylphenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 8	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750183	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750183&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118227	519648777							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1540997	Cc1cc(NC(=O)C(O)c2cccc(F)c2)ccc1-c1nc(C)n2c(C)cnc(N)c12			750184	N-(4-(8-amino-3,5- dimethylimidazo[1,5- a]pyrazin-1-yl)-3- methylphenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 9	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 75							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750184	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750184&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118227	519648778							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1540998	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)cc2C)c2c(N)ncc(C)n12			750185	N-(4-(8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl)-3- methylphenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 10	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750185	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750185&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118322	519648779							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1540999	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)cc2C)c2c(N)ncc(C)n12			750186	N-(4-(8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl)-3- methylphenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 11	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750186	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750186&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118322	519648780							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541000	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2C)c2c(N)nc(C)cn12			750187	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 14	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750187	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750187&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118364	519648781							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541001	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2C)c2c(N)nc(C)cn12			750188	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 15	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 175							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750188	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750188&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118364	519648782							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541002	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2C)c2c(N)ncc(C)n12			750189	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 16	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 1500							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750189	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750189&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118246	519648783							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541003	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2C)c2c(N)ncc(C)n12			750190	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 17	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750190	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750190&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118246	519648784							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541004	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2C)c2c(N)ncc(Cl)n12			750191	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 18	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750191	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750191&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118337	519648785							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541005	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2C)c2c(N)ncc(Cl)n12			750192	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 19	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750192	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750192&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118337	519648786							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541006	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2C)c2c(N)ncc(C(F)(F)F)n12			750193	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- methyl-phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 20	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750193	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750193&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118279	519648787							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541007	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2C)c2c(N)ncc(C(F)(F)F)n12			750194	N-[4-[8-amino-3- (trideuteriomethyl)- 5- (trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- methyl-phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 21	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 75							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750194	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750194&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118279	519648788							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541008	Cc1cc(NC(=O)C(O)c2cccc(F)c2)ccc1-c1nc(C)n2c(C(F)(F)F)cnc(N)c12			750195	N-(4-(8-amino-3- methyl-5- (trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl)-3- methylphenyl)-2- (3-fluorophenyl)-2- hydroxyacetamide::US12331054, Example 26	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750195	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750195&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118141	519648789							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541009	Cc1cc(NC(=O)C(O)c2cccc(F)c2)ccc1-c1nc(C)n2c(C(F)(F)F)cnc(N)c12			750196	N-(4-(8-amino-3- methyl-5- (trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl)-3- methylphenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 27	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750196	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750196&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118141	519648790							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541010	Cc1cc(NC(=O)C(O)c2cccc(F)c2)ccc1-c1nc(C)n2c(Cl)cnc(N)c12			750197	N-(4-(8-amino-5- chloro-3- methylimidazo[1,5- a]pyrazin-1-yl)-3- methylphenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 28	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750197	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750197&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118258	519648791							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541011	Cc1cc(NC(=O)C(O)c2cccc(F)c2)ccc1-c1nc(C)n2c(Cl)cnc(N)c12			750198	N-(4-(8-amino-5- chloro-3- methylimidazo[1,5- a]pyrazin-1-yl)-3- methylphenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 29	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750198	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750198&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118258	519648792							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541012	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)cc2C)c2c(N)ncc(C(F)(F)F)n12			750199	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- methyl-phenyl]-2- (3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 30	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750199	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750199&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118202	519648793							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541013	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)cc2C)c2c(N)ncc(C(F)(F)F)n12			750200	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- methyl-phenyl]-2- (3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 31	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750200	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750200&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118202	519648794							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541014	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)cc2C)c2c(N)ncc(Cl)n12			750201	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- (3-fluorophenyl)-2- hydroxy-acetamide::US12331054, Example 32	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750201	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750201&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118223	519648795							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541015	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)cc2C)c2c(N)ncc(Cl)n12			750202	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- (3-fluorophenyl)-2- hydroxy-acetamide::US12331054, Example 33	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750202	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750202&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118223	519648796							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541016	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)cc2C)c2c(N)nc(C)cn12			750203	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- (3-chlorophenyl)-2- hydroxy-acetamide::US12331054, Example 34	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750203	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750203&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118139	519648797							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541017	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)cc2C)c2c(N)nc(C)cn12			750204	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- (3-chlorophenyl)-2- hydroxy-acetamide::US12331054, Example 35	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 175							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750204	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750204&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118139	519648798							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541018	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)cc2C)c2c(N)ncc(C)n12			750205	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- (3-chlorophenyl)-2- hydroxy-acetamide::US12331054, Example 36	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750205	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750205&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118283	519648799							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541019	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)cc2C)c2c(N)ncc(C)n12			750206	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- (3-chlorophenyl)-2- hydroxy-acetamide::US12331054, Example 37	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750206	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750206&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118283	519648800							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541020	Cc1cc(NC(=O)C(O)c2cccc(Cl)c2)ccc1-c1nc(C)n2c(C)cnc(N)c12			750207	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)-3-methyl- phenyl)-2-(3- chlorophenyl)-2- hydroxyacetamide::US12331054, Example 38	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750207	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750207&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118082	519648801							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541021	Cc1cc(NC(=O)C(O)c2cccc(Cl)c2)ccc1-c1nc(C)n2c(C)cnc(N)c12			750208	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)-3-methyl- phenyl)-2-(3- chlorophenyl)-2- hydroxyacetamide::US12331054, Example 39	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750208	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750208&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118082	519648802							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541022	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)cc2C)c2c(N)ncc(C(F)(F)F)n12			750209	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- methyl-phenyl]-2- (3-chlorophenyl)- 2-hydroxy- acetamide::US12331054, Example 40	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750209	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750209&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118320	519648803							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541023	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)cc2C)c2c(N)ncc(C(F)(F)F)n12			750210	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- methyl-phenyl]-2- (3-chlorophenyl)- 2-hydroxy- acetamide::US12331054, Example 41	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750210	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750210&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118320	519648804							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541024	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)cc2C)c2c(N)ncc(Cl)n12			750211	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- (3-chlorophenyl)- 2-hydroxy- acetamide::US12331054, Example 42	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750211	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750211&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118329	519648805							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541025	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)cc2C)c2c(N)ncc(Cl)n12			750212	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- (3-chlorophenyl)- 2-hydroxy- acetamide::US12331054, Example 43	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750212	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750212&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118329	519648806							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541026	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)cc2C)c2c(N)nc(C)cn12			750213	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- (3,5-difluoro- phenyl)-2- hydroxy- acetamide::US12331054, Example 44	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750213	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750213&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118045	519648807							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541027	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)cc2C)c2c(N)nc(C)cn12			750214	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-3- methyl-phenyl]-2- (3,5-difluoro- phenyl)-2- hydroxy- acetamide::US12331054, Example 45	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 75							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750214	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750214&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118045	519648808							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541028	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)cc2C)c2c(N)ncc(C(F)(F)F)n12			750215	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- methyl-phenyl]-2- (3,5-difluoro- phenyl)-2- hydroxy- acetamide::US12331054, Example 46	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750215	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750215&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118242	519648809							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541029	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)cc2C)c2c(N)ncc(C(F)(F)F)n12			750216	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- methyl-phenyl]-2- (3,5-difluoro- phenyl)-2- hydroxy- acetamide::US12331054, Example 47	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 38							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750216	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750216&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118242	519648810							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541030	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)cc2C)c2c(N)ncc(Cl)n12			750217	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- (3,5-difluoro- phenyl)-2- hydroxy- acetamide::US12331054, Example 48	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750217	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750217&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118076	519648811							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541031	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)cc2C)c2c(N)ncc(Cl)n12			750218	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-3- methyl-phenyl]-2- (3,5-difluoro- phenyl)-2- hydroxy- acetamide::US12331054, Example 49	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750218	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750218&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118076	519648812							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541032	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)cc2C)c2c(N)ncc(C)n12			750219	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-3- methyl-phenyl]-2- (3,5-difluoro- phenyl)-2- hydroxy- acetamide::US12331054, Example 50	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750219	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750219&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118132	519648813							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541033	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)cc2C)c2c(N)ncc(C)n12			750220	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- (3,5-difluoro- phenyl)-2- hydroxy- acetamide::US12331054, Example 51	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750220	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750220&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118132	519648814							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541034	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)cc2C)c2c(N)nc(C)cn12			750221	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-3- methyl-phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2-hydroxy- acetamide::US12331054, Example 52	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750221	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750221&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118127	519648815							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541035	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)cc2C)c2c(N)nc(C)cn12			750222	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-3- methyl-phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2-hydroxy- acetamide::US12331054, Example 53	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 175							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750222	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750222&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118127	519648816							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541036	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)cc2C)c2c(N)ncc(C)n12			750223	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-3- methyl-phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2-hydroxy- acetamide::US12331054, Example 54	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750223	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750223&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118114	519648817							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541037	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)cc2C)c2c(N)ncc(C)n12			750224	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2-hydroxy- acetamide::US12331054, Example 55	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750224	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750224&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118114	519648818							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541038	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)cc2C)c2c(N)ncc(Cl)n12			750225	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2-hydroxy- acetamide::US12331054, Example 56	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750225	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750225&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118282	519648819							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541039	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)cc2C)c2c(N)ncc(Cl)n12			750226	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- methyl-phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2-hydroxy- acetamide::US12331054, Example 57	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750226	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750226&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118282	519648820							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541040	Cc1cc(NC(=O)C(O)c2cc(F)cc(C(F)(F)F)c2)ccc1-c1nc(C)n2c(C)cnc(N)c12			750227	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)-3- methylphenyl)-2- (3-fluoro-5- (trifluoromethyl) phenyl)-2- hydroxyacetamide::US12331054, Example 58	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750227	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750227&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118134	519648821							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541041	Cc1cc(NC(=O)C(O)c2cc(F)cc(C(F)(F)F)c2)ccc1-c1nc(C)n2c(C)cnc(N)c12			750228	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1-yl)- 3-methylphenyl)- 2-(3-fluoro-5- (trifluoromethyl) phenyl)-2- hydroxyacetamide::US12331054, Example 59	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750228	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750228&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118134	519648822							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541042	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)cc2C)c2c(N)ncc(C(F)(F)F)n12			750229	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- methyl-phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2-hydroxy- acetamide::US12331054, Example 60	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750229	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750229&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118425	519648823							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541043	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)cc2C)c2c(N)ncc(C(F)(F)F)n12			750230	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- methyl-phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2-hydroxy- acetamide::US12331054, Example 61	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 75							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750230	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750230&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118425	519648824							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541044	Cc1cc(F)cc(C(O)C(=O)Nc2ccc(-c3nc(C)n4c(C)cnc(N)c34)c(C)c2)c1			750231	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)-3-methyl- phenyl)-2-(3- fluoro-5- methylphenyl)-2- hydroxyacetamide::US12331054, Example 62	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750231	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750231&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118112	519648825							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541045	Cc1cc(F)cc(C(O)C(=O)Nc2ccc(-c3nc(C)n4c(C)cnc(N)c34)c(C)c2)c1			750232	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)-3-methyl- phenyl)-2-(3- fluoro-5- methylphenyl)-2- hydroxyacetamide::US12331054, Example 63	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750232	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750232&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118112	519648826							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541046	Cc1cc(NC(=O)C(O)c2cccc(F)c2)c(F)cc1-c1nc(C)n2c(C)cnc(N)c12			750233	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)-2-fluoro-5- methylphenyl)-2- (3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 64	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 75							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750233	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750233&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118245	519648827							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541047	Cc1cc(NC(=O)C(O)c2cccc(F)c2)c(F)cc1-c1nc(C)n2c(C)cnc(N)c12			750234	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)-2-fluoro-5- methylphenyl)-2- (3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 65	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750234	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750234&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118245	519648828							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541048	CCc1cc(NC(=O)C(O)c2cccc(F)c2)ccc1-c1nc(C)n2c(C)cnc(N)c12			750235	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)-3-ethylphenyl)- 2-(3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 66	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750235	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750235&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118233	519648829							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541049	CCc1cc(NC(=O)C(O)c2cccc(F)c2)ccc1-c1nc(C)n2c(C)cnc(N)c12			750236	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)-3-ethylphenyl)- 2-(3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 67	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750236	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750236&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118233	519648830							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541050	Cc1cnc(N)c2c(-c3ccc(NC(=O)C(O)c4cccc(F)c4)cc3)nc(C)n12			750237	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)phenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 68	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750237	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750237&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118272	519648831							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541051	Cc1cnc(N)c2c(-c3ccc(NC(=O)C(O)c4cccc(F)c4)cc3)nc(C)n12			750238	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)phenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 69	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750238	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750238&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118272	519648832							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541052	Cc1cnc(N)c2c(-c3ccc(NC(=O)C(O)c4cccc(F)c4)cc3F)nc(C)n12			750239	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)-3-fluorophenyl)- 2-(3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 70	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750239	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750239&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118230	519648833							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541053	Cc1cnc(N)c2c(-c3ccc(NC(=O)C(O)c4cccc(F)c4)cc3F)nc(C)n12			750240	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)-3-fluorophenyl)- 2-(3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 71	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750240	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750240&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118230	519648834							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541054	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)cc2F)c2c(N)ncc(C)n12			750241	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- (3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 72	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750241	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750241&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118252	519648835							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541055	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)cc2F)c2c(N)ncc(C)n12			750242	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-3- fluoro-phenyl]-2- (3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 73	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750242	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750242&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118252	519648836							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541056	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)cc2F)c2c(N)ncc(Cl)n12			750243	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]- 3-fluoro-phenyl]- 2-(3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 74	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750243	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750243&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118116	519648837							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541057	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)cc2F)c2c(N)ncc(Cl)n12			750244	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- (3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 75	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750244	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750244&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118116	519648838							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541058	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)cc2F)c2c(N)ncc(C(F)(F)F)n12			750245	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- fluoro-phenyl]-2- (3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 76	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750245	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750245&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			166018975	519648839							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541059	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)cc2F)c2c(N)ncc(C(F)(F)F)n12			750246	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- fluoro-phenyl]-2- (3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 77	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750246	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750246&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			166018975	519648840							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541060	Cc1cnc(N)c2c(-c3ccc(NC(=O)C(O)c4cccc(Cl)c4)cc3F)nc(C)n12			750247	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)-3-fluorophenyl)- 2-(3-chlorophenyl)- 2-hydroxy- acetamide::US12331054, Example 78	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750247	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750247&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118231	519648841							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541061	Cc1cnc(N)c2c(-c3ccc(NC(=O)C(O)c4cccc(Cl)c4)cc3F)nc(C)n12			750248	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)-3-fluorophenyl)- 2-(3-chlorophenyl)- 2-hydroxy- acetamide::US12331054, Example 79	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750248	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750248&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118231	519648842							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541062	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)cc2F)c2c(N)nc(C)cn12			750249	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- (3-chlorophenyl)- 2-hydroxy- acetamide::US12331054, Example 80	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750249	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750249&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118121	519648843							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541063	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)cc2F)c2c(N)nc(C)cn12			750250	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- (3-chlorophenyl)- 2-hydroxy- acetamide::US12331054, Example 81	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750250	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750250&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118121	519648844							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541064	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)cc2F)c2c(N)ncc(C(F)(F)F)n12			750251	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- fluoro-phenyl]-2- (3-chlorophenyl)- 2-hydroxy- acetamide::US12331054, Example 82	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750251	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750251&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118240	519648845							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541065	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)cc2F)c2c(N)ncc(C(F)(F)F)n12			750252	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- fluoro-phenyl]-2- (3-chlorophenyl)- 2-hydroxy- acetamide::US12331054, Example 83	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750252	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750252&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118240	519648846							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541066	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)cc2F)c2c(N)ncc(C)n12			750253	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]- 3-fluoro-phenyl]- 2-(3-chlorophenyl)- 2-hydroxy- acetamide::US12331054, Example 84	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750253	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750253&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118302	519648847							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541067	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)cc2F)c2c(N)ncc(C)n12			750254	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- (3-chlorophenyl)- 2-hydroxy- acetamide::US12331054, Example 85	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750254	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750254&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118302	519648848							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541068	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)cc2F)c2c(N)ncc(Cl)n12			750255	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- (3-chlorophenyl)- 2-hydroxy- acetamide::US12331054, Example 86	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750255	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750255&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118273	519648849							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541069	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)cc2F)c2c(N)ncc(Cl)n12			750256	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- (3-chlorophenyl)- 2-hydroxy- acetamide::US12331054, Example 87	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750256	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750256&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118273	519648850							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541070	Cc1cccc(C(O)C(=O)Nc2ccc(-c3nc(C)n4c(C)cnc(N)c34)c(F)c2)c1			750257	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)-3-fluoro- phenyl)-2- hydroxy-2-(m- tolyl)acetamide::US12331054, Example 88	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750257	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750257&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118100	519648851							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541071	Cc1cccc(C(O)C(=O)Nc2ccc(-c3nc(C)n4c(C)cnc(N)c34)c(F)c2)c1			750258	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)-3-fluoro- phenyl)-2- hydroxy-2-(m- tolyl)acetamide::US12331054, Example 89	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750258	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750258&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118100	519648852							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541072	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C)c3)cc2F)c2c(N)ncc(C)n12			750259	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- hydroxy-2-(m- tolyl)acetamide::US12331054, Example 90	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750259	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750259&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118368	519648853							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541073	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C)c3)cc2F)c2c(N)ncc(C)n12			750260	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- hydroxy-2-(m- tolyl)acetamide::US12331054, Example 91	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750260	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750260&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118368	519648854							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541074	Cc1cnc(N)c2c(-c3ccc(NC(=O)C(O)c4cccc(C(F)(F)F)c4)cc3F)nc(C)n12			750261	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)-3-fluoro- phenyl)-2- hydroxy-2-(3- (trifluoromethyl) phenyl)acetamide::US12331054, Example 92	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750261	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750261&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118326	519648855							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541075	Cc1cnc(N)c2c(-c3ccc(NC(=O)C(O)c4cccc(C(F)(F)F)c4)cc3F)nc(C)n12			750262	N-(4-(8-amino-3,5- dimethylimidazo [1,5-a]pyrazin-1- yl)-3-fluoro- phenyl)-2- hydroxy-2-(3- (trifluoromethyl) phenyl)acetamide::US12331054, Example 93	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750262	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750262&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118326	519648856							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541076	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2F)c2c(N)ncc(C)n12			750263	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 94	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750263	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750263&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118346	519648857							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541077	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2F)c2c(N)ncc(C)n12			750264	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 95	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750264	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750264&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118346	519648858							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541078	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2F)c2c(N)nc(C)cn12			750265	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 96	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750265	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750265&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118294	519648859							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541079	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2F)c2c(N)nc(C)cn12			750266	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 97	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 30							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750266	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750266&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118294	519648860							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541080	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2F)c2c(N)ncc(C(F)(F)F)n12			750267	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]- 3-fluoro-phenyl]- 2-hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 98	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750267	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750267&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118148	519648861							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541081	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2F)c2c(N)ncc(C(F)(F)F)n12			750268	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- fluoro-phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 99	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 38							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750268	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750268&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118148	519648862							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541082	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2F)c2c(N)ncc(Cl)n12			750269	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 100	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750269	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750269&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118147	519648863							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541083	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2F)c2c(N)ncc(Cl)n12			750270	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 101	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750270	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750270&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118147	519648864							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541084	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)cc2F)c2c(N)nc(C)cn12			750271	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- (3,5-difluoro- phenyl)-2- hydroxy-acetamide::US12331054, Example 102	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750271	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750271&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118254	519648865							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541085	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)cc2F)c2c(N)nc(C)cn12			750272	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- (3,5-difluoro- phenyl)-2- hydroxy-acetamide::US12331054, Example 103	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750272	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750272&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118254	519648866							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541086	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)cc2F)c2c(N)ncc(C)n12			750273	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- (3,5-difluoro- phenyl)-2- hydroxy-acetamide::US12331054, Example 104	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750273	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750273&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118103	519648867							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541087	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)cc2F)c2c(N)ncc(C)n12			750274	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- (3,5-difluoro- phenyl)-2- hydroxy-acetamide::US12331054, Example 105	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750274	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750274&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118103	519648868							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541088	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)cc2F)c2c(N)ncc(C(F)(F)F)n12			750275	N-[4-[8-amino-3- (trideuteriomethyl)- 5- (trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- fluoro-phenyl]-2- (3,5-difluoro- phenyl)-2- hydroxy-acetamide::US12331054, Example 106	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750275	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750275&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118241	519648869							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541089	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)cc2F)c2c(N)ncc(C(F)(F)F)n12			750276	N-[4-[8-amino-3- (trideuteriomethyl)- 5- (trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- fluoro-phenyl]-2- (3,5-difluoro- phenyl)-2- hydroxy-acetamide::US12331054, Example 107	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750276	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750276&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118241	519648870							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541090	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)cc2F)c2c(N)ncc(Cl)n12			750277	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- (3,5-difluoro- phenyl)-2- hydroxy-acetamide::US12331054, Example 108	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750277	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750277&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118247	519648871							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541091	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)cc2F)c2c(N)ncc(Cl)n12			750278	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- (3,5-difluoro- phenyl)-2- hydroxy-acetamide::US12331054, Example 109	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750278	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750278&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118247	519648872							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541092	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)cc2F)c2c(N)ncc(C)n12			750279	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2- hydroxy-acetamide::US12331054, Example 110	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750279	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750279&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118093	519648873							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541093	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)cc2F)c2c(N)ncc(C)n12			750280	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2- hydroxy-acetamide::US12331054, Example 111	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750280	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750280&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118093	519648874							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541094	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)cc2F)c2c(N)ncc(C(F)(F)F)n12			750281	N-[4-[8-amino-3- (trideuteriomethyl)- 5- (trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- fluoro-phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2- hydroxy-acetamide::US12331054, Example 112	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750281	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750281&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118306	519648875							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541095	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)cc2F)c2c(N)ncc(C(F)(F)F)n12			750282	N-[4-[8-amino-3- (trideuteriomethyl)- 5- (trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-3- fluoro-phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2- hydroxy-acetamide::US12331054, Example 113	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 75							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750282	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750282&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118306	519648876							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541096	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)cc2F)c2c(N)ncc(Cl)n12			750283	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2- hydroxy-acetamide::US12331054, Example 114	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750283	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750283&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118418	519648877							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541097	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)cc2F)c2c(N)ncc(Cl)n12			750284	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]- 3-fluoro-phenyl]- 2-[3-fluoro-5- (trifluoromethyl) phenyl]-2- hydroxy-acetamide::US12331054, Example 115	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750284	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750284&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118418	519648878							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541098	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)cc2F)c2c(N)nc(C)cn12			750285	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2- hydroxy-acetamide::US12331054, Example 116	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750285	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750285&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118257	519648879							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541099	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)cc2F)c2c(N)nc(C)cn12			750286	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5- a]pyrazin-1-yl]-3- fluoro-phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2- hydroxy-acetamide::US12331054, Example 117	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 75							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750286	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750286&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118257	519648880							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541100	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)c(F)c2)c2c(N)ncc(C)n12			750287	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2- fluoro-phenyl]-2- (3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 122	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 38							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750287	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750287&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118341	519648881							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541101	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)c(F)c2)c2c(N)ncc(C)n12			750288	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2- fluoro-phenyl]-2- (3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 123	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750288	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750288&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118341	519648882							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541102	Cc1cnc(N)c2c(-c3ccc(NC(=O)C(O)c4cccc(F)c4)c(F)c3)nc(C)n12			750289	N-(4-(8-amino- 3,5-dimethyl- imidazo[1,5-a] pyrazin-1-yl)-2- fluorophenyl)-2- (3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 124	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 38							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750289	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750289&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118182	519648883							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541103	Cc1cnc(N)c2c(-c3ccc(NC(=O)C(O)c4cccc(F)c4)c(F)c3)nc(C)n12			750290	N-(4-(8-amino- 3,5-dimethyl- imidazo[1,5-a] pyrazin-1-yl)-2- fluorophenyl)-2- (3-fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 125	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750290	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750290&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118182	519648884							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541104	Cc1cnc(N)c2c(-c3ccc(NC(=O)C(O)c4cccc(F)c4)cc3OC(F)(F)F)nc(C)n12			750291	N-(4-(8-amino- 3,5-dimethyl- imidazo[1,5-a] pyrazin-1-yl)-3- (trifluoromethoxy) phenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 126	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 175							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750291	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750291&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156134137	519648885							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541105	Cc1cnc(N)c2c(-c3ccc(NC(=O)C(O)c4cccc(F)c4)cc3OC(F)(F)F)nc(C)n12			750292	N-(4-(8-amino- 3,5-dimethyl- imidazo[1,5-a] pyrazin-1-yl)-3- (trifluoromethoxy) phenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 127	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750292	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750292&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156134137	519648886							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541106	Cc1cn2c(C)nc(-c3ccc(NC(=O)C(O)c4cccc(F)c4)c(F)c3F)c2c(N)n1			750293	N-(4-(8-amino- 3,6-dimethyl- imidazo[1,5-a] pyrazin-1-yl)- 2,3-difluoro- phenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 128	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750293	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750293&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118251	519648887							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541107	Cc1cn2c(C)nc(-c3ccc(NC(=O)C(O)c4cccc(F)c4)c(F)c3F)c2c(N)n1			750294	N-(4-(8-amino- 3,6-dimethyl- imidazo[1,5-a] pyrazin-1-yl)- 2,3-difluoro- phenyl)-2-(3- fluorophenyl)-2- hydroxyacetamide::US12331054, Example 129	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 750							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750294	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750294&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118251	519648888							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541108	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)c(F)c2F)c2c(N)nc(C)cn12			750295	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro-phenyl]- 2-(3-fluoro- phenyl)-2- hydroxy- acetamide::US12331054, Example 130	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750295	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750295&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118049	519648889							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541109	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)c(F)c2F)c2c(N)nc(C)cn12			750296	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro-phenyl]- 2-(3-fluoro- phenyl)-2- hydroxy- acetamide::US12331054, Example 131	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 750							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750296	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750296&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118049	519648890							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541110	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)c(F)c2F)c2c(N)ncc(C)n12			750297	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro-phenyl]- 2-(3-fluoro- phenyl)-2- hydroxy- acetamide::US12331054, Example 132	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750297	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750297&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118146	519648891							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541111	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)c(F)c2F)c2c(N)ncc(C)n12			750298	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro-phenyl]- 2-(3-fluoro- phenyl)-2- hydroxy- acetamide::US12331054, Example 133	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750298	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750298&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118146	519648892							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541112	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)c(F)c2F)c2c(N)ncc(C(F)(F)F)n12			750299	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-(3- fluorophenyl)-2- hydroxy- acetamide::US12331054, Example 134	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750299	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750299&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118297	519648893							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541113	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)c(F)c2F)c2c(N)ncc(C(F)(F)F)n12			750300	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-(3- fluorophenyl)-2- hydroxy- acetamide::US12331054, Example 135	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 175							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750300	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750300&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118297	519648894							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541114	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)c(F)c2F)c2c(N)ncc(Cl)n12			750301	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro-phenyl]- 2-(3-fluoro- phenyl)-2- hydroxy- acetamide::US12331054, Example 136	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750301	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750301&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118318	519648895							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541115	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)c(F)c2F)c2c(N)ncc(Cl)n12			750302	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro-phenyl]- 2-(3-fluoro- phenyl)-2- hydroxy- acetamide::US12331054, Example 137	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750302	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750302&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118318	519648896							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541116	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)c(F)c2F)c2c(N)ncc(C)n12			750303	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro-phenyl]- 2-(3-chloro- phenyl)-2- hydroxy- acetamide::US12331054, Example 138	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750303	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750303&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118094	519648897							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541117	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)c(F)c2F)c2c(N)ncc(C)n12			750304	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-(3- chlorophenyl)-2- hydroxy- acetamide::US12331054, Example 139	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750304	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750304&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118094	519648898							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541118	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)c(F)c2F)c2c(N)nc(C)cn12			750305	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-(3- chlorophenyl)-2- hydroxy- acetamide::US12331054, Example 140	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750305	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750305&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118234	519648899							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541119	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)c(F)c2F)c2c(N)nc(C)cn12			750306	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-(3- chlorophenyl)-2- hydroxy- acetamide::US12331054, Example 141	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 75							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750306	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750306&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118234	519648900							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541120	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)c(F)c2F)c2c(N)ncc(C(F)(F)F)n12			750307	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-(3- chlorophenyl)-2- hydroxy- acetamide::US12331054, Example 142	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750307	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750307&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118348	519648901							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541121	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)c(F)c2F)c2c(N)ncc(C(F)(F)F)n12			750308	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-(3- chlorophenyl)-2- hydroxy- acetamide::US12331054, Example 143	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 375							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750308	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750308&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118348	519648902							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541122	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)c(F)c2F)c2c(N)ncc(Cl)n12			750309	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-(3- chlorophenyl)-2- hydroxy- acetamide::US12331054, Example 144	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750309	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750309&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118301	519648903							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541123	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(Cl)c3)c(F)c2F)c2c(N)ncc(Cl)n12			750310	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-(3- chlorophenyl)-2- hydroxy- acetamide::US12331054, Example 145	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750310	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750310&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118301	519648904							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541124	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)c(F)c2F)c2c(N)ncc(C)n12			750311	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 146	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750311	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750311&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118090	519648905							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541125	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)c(F)c2F)c2c(N)ncc(C)n12			750312	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 147	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 38							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750312	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750312&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118090	519648906							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541126	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)c(F)c2F)c2c(N)ncc(C(F)(F)F)n12			750313	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 148	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750313	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750313&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118160	519648907							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541127	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)c(F)c2F)c2c(N)ncc(C(F)(F)F)n12			750314	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]- 2-hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 149	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 750							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750314	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750314&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118160	519648908							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541128	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)c(F)c2F)c2c(N)nc(C)cn12			750315	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 150	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750315	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750315&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118117	519648909							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541129	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)c(F)c2F)c2c(N)nc(C)cn12			750316	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 151	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 75							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750316	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750316&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118117	519648910							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541130	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)c(F)c2F)c2c(N)ncc(Cl)n12			750317	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 152	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750317	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750317&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118152	519648911							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541131	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)c(F)c2F)c2c(N)ncc(Cl)n12			750318	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 153	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 38							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750318	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750318&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118152	519648912							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541132	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)c(F)c2F)c2c(N)ncc(C)n12			750319	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-(3,5- difluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 154	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750319	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750319&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118226	519648913							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541133	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)c(F)c2F)c2c(N)ncc(C)n12			750320	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-(3,5- difluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 155	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750320	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750320&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118226	519648914							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541134	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)c(F)c2F)c2c(N)ncc(Cl)n12			750321	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-(3,5- difluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 156	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750321	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750321&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118129	519648915							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541135	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)c(F)c2F)c2c(N)ncc(Cl)n12			750322	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-(3,5- difluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 157	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750322	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750322&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118129	519648916							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541136	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)c(F)c2F)c2c(N)ncc(C(F)(F)F)n12			750323	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-(3,5- difluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 158	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750323	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750323&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			166018978	519648917							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541137	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(F)c3)c(F)c2F)c2c(N)ncc(C(F)(F)F)n12			750324	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-(3,5- difluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 159	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 75							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750324	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750324&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			166018978	519648918							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541138	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)c(F)c2F)c2c(N)ncc(C)n12			750325	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2- hydroxy- acetamide::US12331054, Example 160	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750325	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750325&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118149	519648919							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541139	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)c(F)c2F)c2c(N)ncc(C)n12			750326	N-[4-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2- hydroxy- acetamide::US12331054, Example 161	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750326	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750326&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118149	519648920							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541140	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)c(F)c2F)c2c(N)ncc(C(F)(F)F)n12			750327	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-[3- fluoro-5- (trifluoromethyl) phenyl]-2- hydroxy- acetamide::US12331054, Example 162	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750327	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750327&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118427	519648921							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541141	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)c(F)c2F)c2c(N)ncc(C(F)(F)F)n12			750328	N-[4-[8-amino-3- (trideuteriomethyl)- 5-(trifluoromethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-[3- fluoro-5- (trifluoromethyl) phenyl]-2- hydroxy- acetamide::US12331054, Example 163	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 375							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750328	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750328&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118427	519648922							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541142	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)c(F)c2F)c2c(N)ncc(Cl)n12			750329	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro-phenyl]- 2-[3-fluoro-5- (trifluoromethyl) phenyl]-2- hydroxy- acetamide::US12331054, Example 164	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750329	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750329&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118052	519648923							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541143	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)c(F)c2F)c2c(N)ncc(Cl)n12			750330	N-[4-[8-amino-5- chloro-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2- hydroxy- acetamide::US12331054, Example 165	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 38							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750330	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750330&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118052	519648924							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541144	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)c(F)c2F)c2c(N)nc(C)cn12			750331	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2-[3- fluoro-5- (trifluoromethyl) phenyl]-2- hydroxy- acetamide::US12331054, Example 166	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750331	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750331&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118101	519648925							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541145	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cc(F)cc(C(F)(F)F)c3)c(F)c2F)c2c(N)nc(C)cn12			750332	N-[4-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-2,3- difluoro- phenyl]-2- [3-fluoro-5- (trifluoromethyl) phenyl]-2- hydroxy- acetamide::US12331054, Example 167	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 38							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750332	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750332&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118101	519648926							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541146	Cc1c(-c2nc(C)n3c(C)cnc(N)c23)ccc(NC(=O)C(O)c2cccc(F)c2)c1F			750333	N-(4-(8-amino- 3,5-dimethyl- imidazo[1,5-a] pyrazin-1-yl)-2- fluoro-3-methyl- phenyl)-2-(3- fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 168	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750333	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750333&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118276	519648927							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541147	Cc1c(-c2nc(C)n3c(C)cnc(N)c23)ccc(NC(=O)C(O)c2cccc(F)c2)c1F			750334	N-(4-(8-amino- 3,5-dimethyl- imidazo[1,5-a] pyrazin-1-yl)-2- fluoro-3-methyl- phenyl)-2-(3- fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 169	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750334	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750334&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118276	519648928							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541148	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)nc2C)c2c(N)nc(C)cn12			750335	N-[5-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-6- methyl-2- pyridyl]-2-(3- fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 170	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750335	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750335&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118216	519648929							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541149	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)nc2C)c2c(N)nc(C)cn12			750336	N-[5-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-6- methyl-2- pyridyl]-2-(3- fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 171	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 1500							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750336	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750336&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118216	519648930							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541150	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)nc2C)c2c(N)ncc(C)n12			750337	N-[5-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-6- methyl-2- pyridyl]-2-(3- fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 172	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 30							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750337	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750337&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118373	519648931							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541151	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(F)c3)nc2C)c2c(N)ncc(C)n12			750338	N-[5-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-6- methyl-2- pyridyl]-2-(3- fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 173	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750338	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750338&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118373	519648932							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541152	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)nc2C)c2c(N)ncc(C)n12			750339	N-[5-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-6- methyl-2- pyridyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 174	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750339	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750339&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118123	519648933							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541153	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)nc2C)c2c(N)ncc(C)n12			750340	N-[5-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-6- methyl-2- pyridyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 175	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750340	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750340&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118123	519648934							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541154	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)nc2C)c2c(N)nc(C)cn12			750341	N-[5-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-6- methyl-2- pyridyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 176	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750341	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750341&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			166018973	519648935							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541155	[2H]C([2H])([2H])c1nc(-c2ccc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)nc2C)c2c(N)nc(C)cn12			750342	N-[5-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-6- methyl-2- pyridyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 177	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 175							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750342	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750342&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			166018973	519648936							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541156	[2H]C([2H])([2H])c1nc(-c2cnc(NC(=O)C(O)c3cccc(F)c3)cc2C)c2c(N)nc(C)cn12			750343	N-[5-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-4- methyl-2- pyridyl]-2-(3- fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 178	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 375							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750343	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750343&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118299	519648937							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541157	[2H]C([2H])([2H])c1nc(-c2cnc(NC(=O)C(O)c3cccc(F)c3)cc2C)c2c(N)nc(C)cn12			750344	N-[5-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-4- methyl-2- pyridyl]-2-(3- fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 179	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750344	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750344&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118299	519648938							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541158	[2H]C([2H])([2H])c1nc(-c2cnc(NC(=O)C(O)c3cccc(F)c3)cc2C)c2c(N)ncc(C)n12			750345	N-[5-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-4- methyl-2- pyridyl]-2-(3- fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 180	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 38							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750345	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750345&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118142	519648939							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541159	[2H]C([2H])([2H])c1nc(-c2cnc(NC(=O)C(O)c3cccc(F)c3)cc2C)c2c(N)ncc(C)n12			750346	N-[5-[8-amino-5- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-4- methyl-2- pyridyl]-2-(3- fluorophenyl)- 2-hydroxy- acetamide::US12331054, Example 181	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750346	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750346&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			156118142	519648940							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541160	[2H]C([2H])([2H])c1nc(-c2cnc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2C)c2c(N)nc(C)cn12			750347	N-[5-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-4- methyl-2- pyridyl]-2- hydroxy-2-[3- (trifluoromethyl) phenyl]acetamide::US12331054, Example 182	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			<25							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750347	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750347&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			166018979	519648941							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1541161	[2H]C([2H])([2H])c1nc(-c2cnc(NC(=O)C(O)c3cccc(C(F)(F)F)c3)cc2C)c2c(N)nc(C)cn12			750348	N-[5-[8-amino-6- methyl-3- (trideuteriomethyl) imidazo[1,5-a] pyrazin-1-yl]-4- methyl-2- pyridyl]-2- hydroxy-2-[3- (tnfluoromethyl) phenyl]acetamide::US12331054, Example 183	Interferon-induced, double-stranded RNA-activated protein kinase /Eukaryotic translation initiation factor 2-alpha kinase 3 [536-1116]/Small ubiquitin-related modifier 1/eIF-2-alpha kinase GCN2 			 375							US Patent		10.7270/Q24F1W9H			US12331054	Mulvihill, MJ; Li, A; Surman, MD	6/17/2025	10/9/2025	Hibercell	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=750348	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=468&target=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=750348&enzyme=Interferon-induced%2C+double-stranded+RNA-activated+protein+kinase+%2FEukaryotic+translation+initiation+factor+2-alpha+kinase+3+%5B536-1116%5D%2FSmall+ubiquitin-related+modifier+1%2FeIF-2-alpha+kinase+GCN2+&column=ki&startPg=0&Increment=50&submit=Search			166018979	519648942							5	MKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC	6D3L,6D3K,2A1A,2A19	Interferon-induced, double-stranded RNA-activated protein kinase	E2AK2_HUMAN	P19525	A8K3P0 D6W584 E9PC80 Q52M43 Q7Z6F6 Q9UIR4							TTFIVRRLFHPHPHRQRKESETQCQTENKYDSVSGEANDSSWNDIKNSGYISRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEAPPEKWQEKMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFATKEHIEIIAPSPQRSRSFSVGISCDQTSSSESQFSPLEFSGMDHEDISESVDAAYNLQDSCLTDCDVEDGTMDGNDEGHSFELCPSEASPYVRSRERTSSSIVFEDSGCDNASSKEEPKTNRLHIGNHCANKLTAFKPTSSKSSSEATLSISPPRPTTLSLDLTKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSRSLSSSGTKHSRQSNNSHSPLPSN		Interferon-induced, double-stranded RNA-activated protein kinase	A0A7P0TAL9_HUMAN	A0A7P0TAL9								MAPSTPLLTVRGSEGLYMVNGPPHFTESTVFPRESGKNCKVCIFSKDGTLFAWGNGEKVNIISVTNKGLLHSFDLLKAVCLEFSPKNTVLATWQPYTTSKDGTAGIPNLQLYDVKTGTCLKSFIQKKMQNWCPSWSEDETLCARNVNNEVHFFENNNFNTIANKLHLQKINDFVLSPGPQPYKVAVYVPGSKGAPSFVRLYQYPNFAGPHAALANKSFFKADKVTMLWNKKATAVLVIASTDVDKTGASYYGEQTLHYIATNGESAVVQLPKNGPIYDVVWNSSSTEFCAVYGFMPAKATIFNLKCDPVFDFGTGPRNAAYYSPHGHILVLAGFGNLRGQMEVWDVKNYKLISKPVASDSTYFAWCPDGEHILTATCAPRLRVNNGYKIWHYTGSILHKYDVPSNAELWQVSWQPFLDGIFPAKTITYQAVPSEVPNEEPKVATAYRPPALRNKPITNSKLHEEEPPQNMKPQSGNDKPLSKTALKNQRKHEAKKAAKQEARSDKSPDLAPTPAPQSTPRNTVSQSISGDPEIDKKIKNLKKKLKAIEQLKEQAATGKQLEKNQLEKIQKETALLQELEDLELGI	8DYS	Eukaryotic translation initiation factor 2A	EIF2A_HUMAN	Q9BY44	A8MPS6 B4DF96 B4DQ14 D3DNI9 Q5QTR2 Q7Z4E9 Q8NFM1 Q96EW9 Q96K81							SRYFIEFEELQLLGKGAFGAVIKVQNKLDGCCYAVKRIPINPASRQFRRIKGEVTLLSRLHHENIVRYYNAWIERHERPAGPGTPPPDSGPLAKDDRAARGQPASDTDGLDSVEAAAPPPILSSSVEWSTSGERSASARFPATGPGSSDDEDDDEDEHGGVFSQSFLPASDSESDIIFDNEDENSKSQNQDEDCNEKNGCHESEPSVTTEAVHYLYIQMEYCEKSTLRDTIDQGLYRDTVRLWRLFREILDGLAYIHEKGMIHRDLKPVNIFLDSDDHVKIGDFGLATDHLAFSADSKQDDQTGDLIKSDPSGHLTGMVGTALYVSPEVQGSTKSAYNQKVDLFSLGIIFFEMSYHPMVTASERIFVLNQLRDPTSPKFPEDFDDGEHAKQKSVISWLLNHDPAKRPTATELLKSELLPPPQMEESELHEVLHHTL	8T7T,6N3L,6N3O,6N3N	eIF-2-alpha kinase GCN2	E2AK4_HUMAN	Q9P2K8	C9JEC4 Q69YL7 Q6DC97 Q96GN6 Q9H5K1 Q9NSQ3 Q9NSZ5 Q9UJ56							MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV	6XOI,6XOH,6XOG,6JXV,6JXU,2LAS,2N1A,1A5R,2PE6,2MW5,2ASQ,1Y8R,1WYW,2KQS,9DRJ,9DQB,5GHD,5B7A,2N1V,2IY0,2IY1,3UIP,1TGZ,2IO2,1Z5S,5ELJ,8ODR,9Q9E,2G4D,2VRR,2UYZ,9GNV,9GNX,6K5T,2BF8,6TRW	Small ubiquitin-related modifier 1	SUMO1_HUMAN	P63165	A8MUS8 B2R4I5 P55856 Q6FGG0 Q6NZ62 Q93068